PDF
XLS
DOC
DOC
Johnson & Johnson Pricing Transparency Report
View report
Transparency report
Prescription drug net pricing
As net prices decline
Our R&D investments
What we believe
Citations
Fast facts
2022 Executive summary
2022 at a glance
$39 Billion: breaking it down
Rebates, discounts and fees provided to intermediaries
PDABs and UPLs
The 340B program
Archive
Menu
Archive
View report
Transparency report
Prescription drug net pricing
As net prices decline
Our R&D investments
What we believe
Citations
Fast facts
2022 Executive summary
2022 at a glance
$39 Billion: breaking it down
Rebates, discounts and fees provided to intermediaries
PDABs and UPLs
The 340B program
Rebates, discounts and fees provided to intermediaries